Evidence map›Paper›PMID 31726030›Full record

ArticleCell host & microbe2019

Distinct Polysaccharide Utilization Profiles of Human Intestinal Prevotella copri Isolates.

Hannah Fehlner-Peach, Cara Magnabosco, Varsha Raghavan, Jose U Scher, Adrian Tett, Laura M Cox, Claire Gottsegen, Aaron Watters, John D Wiltshire-Gordon, Nicola Segata and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 223 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Bridging the gap:Gut microbes · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Disrupted Gut Viral-Bacterial Ecology of Patients With Liver Cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The dual roles ofFrontiers in oncology · 2026
    Review
  18. Glycoside hydrolase-mediated glucomannan catabolism inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Hannah Fehlner-PeachMolecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Cara MagnaboscoFlatiron Institute Center for Computational Biology, Simons Foundation, New York, NY 10010, USA.
Varsha RaghavanMolecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Jose U ScherDepartment of Medicine, New York University School of Medicine, New York, NY 10016, USA.
Adrian TettCentre for Innovative Biology (CIBIO) Department, University of Trento, Italy.
Laura M CoxHarvard Medical School, Brigham & Women's Hospital, Boston, MA 02115, USA.
Claire GottsegenMolecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Aaron WattersFlatiron Institute Center for Computational Biology, Simons Foundation, New York, NY 10010, USA.
John D Wiltshire-GordonDepartment of Mathematics, University of Wisconsin, Madison, Madison, WI 53706, USA.
Nicola SegataCentre for Innovative Biology (CIBIO) Department, University of Trento, Italy.
Richard BonneauFlatiron Institute Center for Computational Biology, Simons Foundation, New York, NY 10010, USA; New York University, Center for Genomics and Systems Biology, New York, NY 10003, USA.
Dan R LittmanMolecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, New York University School of Medicine, New York, NY 10016, USA. Electronic address: dan.littman@med.nyu.edu.
New York University · USSimons Foundation · USUniversity of Trento · ITBrigham and Women's Hospital · USHoward Hughes Medical Institute · USUniversity of Wisconsin–Madison · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR029893 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2011
$17.7M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
NRSA Training CoreTL1TR001447 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICOLI, KEITH J. · 2015 to 2025
$5.9M
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapyR01AR074500 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Renuka Rajendra Nayak, Jose U. Scher · 2019 to 2026
$4.1M
European Research CouncilHoward Hughes Medical InstituteNCATS NIH HHS TL1 TR001447NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NCI NIH HHS T32 CA009161NCRR NIH HHS UL1 RR029893NIAMS NIH HHS R01 AR074500
6 · The paper itself

Abstract

Gut-dwelling Prevotella copri (P. copri), the most prevalent Prevotella species in the human gut, have been associated with diet and disease. However, our understanding of their diversity and function remains rudimentary because studies have been limited to 16S and metagenomic surveys and experiments using a single type strain. Here, we describe the genomic diversity of 83 P. copri isolates from 11 human donors. We demonstrate that genomically distinct isolates, which can be categorized into different P. copri complex clades, utilize defined sets of polysaccharides. These differences are exemplified by variations in susC genes involved in polysaccharide transport as well as polysaccharide utilization loci (PULs) that were predicted in part from genomic and metagenomic data. Functional validation of these PULs showed that P. copri isolates utilize distinct sets of polysaccharides from dietary plant, but not animal, sources. These findings reveal both genomic and functional differences in polysaccharide utilization across human intestinal P. copri strains.

Indexed as

DietGastrointestinal MicrobiomeGenetic VariationGenome, BacterialHumansIntestinesPlantsPolysaccharidesPrevotellaPolysaccharidesdiethuman microbiomeintestinal commensalswhole genome sequencing

Identifiers

PMID31726030
PMCPMC7039456
OpenAlexW2984090599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.